Adding relatlimab to nivolumab and chemotherapy improved efficacy but did not increase safety concerns in advanced-stage lung cancer. The addition of relatlimab to nivolumab (Opdivo)—a combination ...

Despite the potential competitive advantage of nivolumab (nivo), relatlimab, and chemotherapy in first-line non-small cell lung cancer (NSCLC), there are reservations about the market’s ...

Express consent means that federally regulated financial institutions must get your permission before providing financial products or services to you. This applies to all products and services such as ...

Long-term metastatic melanoma survival dramatically improves on immunotherapy, study finds Date: September 16, 2024 Source: Weill Cornell Medicine Summary: Long-term data from a landmark ...

Colon cancer is the disease characterized by the development of malignant cells in the lining or epithelium of the first and longest portion of the large intestine. In the phase 2 NICHE-3 trial ...

Colorectal cancer, also known as bowel cancer, is a cancer formed by uncontrolled cell growth in the colon or rectum (parts of the large intestine), or in the appendix. Genetic analysis shows that ...

终止原因为：独立数据监测委员会进行的计划分析表明，该试验不太可能实现其主要终点。该安全性与之前报道的nivolumab和relatlimab联合用药的研究一致，该试验并未因安全问题而停止。 但随着多项PD-1单抗联合贝伐珠单抗加化疗或靶向药的II期研究的亮眼数据 ...

To evaluate the frequency and prognostic significance of DTA (DNMT3A、TET2、ASXL1) gene mutation and co-occurring mutations in patients with myelodysplastic syndrome (MDS). The clinical data of 102 ...